Medicus Pharma Ltd. MDCX said Monday it has submitted an optimized Phase 2 study design to the U.S. Food and Drug ...

A higher percentage of total food weight from ultraprocessed food is associated with a higher risk for incident benign prostatic hyperplasia.

HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia ...

Drug Used for Enlarged Prostate Tied to High Glaucoma Risk The use of alpha-blockers for benign prostatic hyperplasia is tied to an increased risk of developing acute angle-closure glaucoma, a study ...

Extracts of the berries of saw palmetto, a small palm tree native to the southeastern U.S., are used widely to treat benign prostatic hyperplasia (BPH). In this randomized trial conducted in ...

PSA clearance after BPE surgery follows a rapid, predictable pattern. Learn how TURP and OSP impact PSA levels and clinical ...

Entadfi is a fixed-dose combination of finasteride, a 5α-reductase inhibitor, and tadalafil, a phosphodiesterase 5 (PDE5) inhibitor. The Food and Drug Administration (FDA) has approved Entadfi ...

Dear Dr. Roach: I am 71 and began having urinary issues due to benign prostatic hyperplasia (BPH) many years ago. I took alpha blockers (Flomax, double Flomax and tadalifil), which didn't provide any ...

HistoSonics reported the successful treatment of the first patients in WOLVERINE, a new trial evaluating the Edison ...

The Knights of Columbus will meet a 7 p.m. April 16 at Father Ragan Hall, at 1783 Moore Road in Avon. Joseph Emery, clinical liaison Lead at University Hospitals Cutler Center for Men, will present ...